Reimbursement Scheme Adhesa®
The health insurer does not fully reimburse Adhesa® 5 mg. The producer of this medicine has therefore asked TBR Nederland to...
Update Reimbursement Scheme Adempas®
As off May 31st 2023, the reimbursement for Adempas® 0.5 mg and 1.0 mg is now also indicated for the treatment of PAH in pediatric...
Reimbursement Scheme Jardiance® - Chronic Kidney Disease
Arrangement for reimbursement by TerugBetaalRegeling Jardiance® (empagliflozin) 10 mg for patients with chronic kidney disease...
Update Reimbursement Scheme Forxiga® - HFpEF
TerugBetaalRegeling Forxiga® (dapagliflozin) 10 mg for patients with symptomatic chronic heart failure with a LVEF ≥ 40% (HFmrEF &...
Reimbursement Scheme Signifor®
The health insurer does not fully reimburse Signifor® 20mg. The producer of this medicine has therefore asked TBR Nederland to...
Select your medicine
Check your medicine expenses
Quickly check the maximum contribution you have to pay for your medicine